Display Settings:

Format
Sort by

Send to:

Choose Destination

    Results: 5

    1.

    Interleukin-6 depletion selectively improves hepatic insulin action in obesity.

    Klover PJ, Clementi AH, Mooney RA.

    Endocrinology. 2005 Aug;146(8):3417-27. Epub 2005 Apr 21.PMID: 15845623 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Hepatocytes: critical for glucose homeostasis.

    Klover PJ, Mooney RA.

    Int J Biochem Cell Biol. 2004 May;36(5):753-8. Review.PMID: 15061128 [PubMed - indexed for MEDLINE]Related articles

    3.

    Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice.

    Klover PJ, Zimmers TA, Koniaris LG, Mooney RA.

    Diabetes. 2003 Nov;52(11):2784-9.PMID: 14578297 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.

    Senn JJ, Klover PJ, Nowak IA, Zimmers TA, Koniaris LG, Furlanetto RW, Mooney RA.

    J Biol Chem. 2003 Apr 18;278(16):13740-6. Epub 2003 Jan 30.PMID: 12560330 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Interleukin-6 induces cellular insulin resistance in hepatocytes.

    Senn JJ, Klover PJ, Nowak IA, Mooney RA.

    Diabetes. 2002 Dec;51(12):3391-9.PMID: 12453891 [PubMed - indexed for MEDLINE]Related articlesFree article